knowledge -WSS

knowledge

author：Wikipedia 2025-09-09 19:32:15 - browse：53

Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT — Adobe

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： ARCH Venture Partners is raising $3 billion for a life sciences fund

hotspot

WSS

Even great ERs can’t make up for American health disparities

General Catalyst, Summa Health deal will turn on physician buy

Cybersecurity threat forces Lurie Children's to take systems offline

Apple Vision Pro: A first look at health apps on the new VR headset

The lessons of Aduhelm, an Alzheimer's drug that was not to be

NIH nominee Bertagnolli will get October confirmation hearing

explore

knowledge

focus

New air purifier tech could be key to improving indoor air quality

Do digital therapeutics have a future in medicine?

Medical leaders decry Supreme Court decision on affirmative action

Woodcock on FDA’s accelerated approval and her next chapter

Affirmative action in medical school literally saved lives

What we need to know about Arena Bioworks

Jerome Adams on the need for new antivirals for Covid

Congressmen charge Covid hearing ‘could have been an email’

Jerome Adams on the need for new antivirals for Covid

Biden administration opens offers in Medicare drug price negotiations

focus

Covid hospitalizations on the rise, Humana says

Quicker fix for pulse oximeters urged during FDA public meeting

Time to name cancers by genetics, not organ of origin, expert says

Snackable artificial intelligence, expert AI, and the pharma industry

How to fix cancer clinical trials' diversity problem

Trump surgeon general acknowledges mistakes during Covid

hotspot

focus

knowledge

hotspot